Scripps Genome ADVISER: Annotation and Distributed Variant Interpretation SERver

Information

  • Research Project
  • 8416328
  • ApplicationId
    8416328
  • Core Project Number
    U01HG006476
  • Full Project Number
    5U01HG006476-02
  • Serial Number
    006476
  • FOA Number
    RFA-HG-10-018
  • Sub Project Id
  • Project Start Date
    2/1/2012 - 12 years ago
  • Project End Date
    12/31/2015 - 8 years ago
  • Program Officer Name
    SOFIA, HEIDI J
  • Budget Start Date
    1/1/2013 - 11 years ago
  • Budget End Date
    12/31/2013 - 10 years ago
  • Fiscal Year
    2013
  • Support Year
    02
  • Suffix
  • Award Notice Date
    1/7/2013 - 11 years ago
Organizations

Scripps Genome ADVISER: Annotation and Distributed Variant Interpretation SERver

DESCRIPTION (provided by applicant): Reductions in sequencing costs and increases in sequencing efficiency are quickly making high-throughput sequencing accessible to individual laboratories looking to use sequencing as a powerful tool in their research endeavors. In fact, as costs continue to decline, we can expect high-throughput sequencing to become a commonly used tool, not only in human phenotype based sequencing projects, but also as an effective tool in forward genetics applications in model organisms, and potentially for the diagnosis idiopathic disease. However, very few laboratories have the computational expertise and infrastructure to make sense of the genetic variants identified through these studies. The goal of this proposal is to make high-throughput sequencing data interpretation as accessible as data generation through expansion of the Scripps Genome Annotation and Distributed Variant Interpretation SERver (SG-ADVISER) and companion data processing and visualization tools. SG-ADVISER is a web-server based tool for holistic, in-depth, annotations and functional predictions of variants generated from high-throughput sequencing. Annotations are formed on at least four major levels: 1) annotation of the genomic element within which a variant resides; 2) prediction of the functional impact of a variant on a genomic element; 3) annotation of molecular and biological processes which link variants across genes and/or genomic elements with one another, and 4) annotation of known clinical characteristics of the gene or variant. The annotations currently provided by SG-ADVISER cover many of these levels of annotation, but are incomplete. Therefore, we propose to expand the capabilities of SG-ADVISER to cover as many generally interesting annotation types as possible, while also extending SG-ADVISER's capabilities to model organism studies. Moreover, we recognize a need for flexibility, and have included a plan to provide customized annotations through the SG-ADVISER web-server. Finally, we feel that truly powerful data interpretation can only be achieved through visualization of massive datasets. Therefore, we propose a plan to produce simple companion tools to process, filter, and visualize SG-ADVISER annotations through currently available genome browsers.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    U01
  • Administering IC
    HG
  • Application Type
    5
  • Direct Cost Amount
    188246
  • Indirect Cost Amount
    80690
  • Total Cost
    268936
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:268936\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZHG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SCRIPPS HEALTH
  • Organization Department
  • Organization DUNS
    131185241
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921211513
  • Organization District
    UNITED STATES